CD30 Positive Primary Mediastinal Large B-cell Lymphoma
1 clinical trials · Condition
◉ Watch CD30 Positive Primary Mediastinal Large B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients (NCT01994850) | Abramson Cancer Center at Penn Medicine | 2013-11-01 |
Track CD30 Positive Primary Mediastinal Large B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.